Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for iBio (IBIO) over the last 14 years, with Q4 2025 value amounting to $516000.0.

  • iBio's Capital Expenditures rose 5150000.0% to $516000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $563000.0, marking a year-over-year increase of 16682.46%. This contributed to the annual value of $16000.0 for FY2025, which is 9238.1% down from last year.
  • Per iBio's latest filing, its Capital Expenditures stood at $516000.0 for Q4 2025, which was up 5150000.0% from $32000.0 recorded in Q3 2025.
  • In the past 5 years, iBio's Capital Expenditures ranged from a high of $3.4 million in Q2 2022 and a low of -$201000.0 during Q1 2023
  • For the 5-year period, iBio's Capital Expenditures averaged around $1.1 million, with its median value being $580000.0 (2022).
  • Per our database at Business Quant, iBio's Capital Expenditures crashed by 13121.12% in 2023 and then soared by 5150000.0% in 2025.
  • iBio's Capital Expenditures (Quarter) stood at $2.1 million in 2021, then surged by 38.49% to $3.0 million in 2022, then tumbled by 82.87% to $506000.0 in 2023, then plummeted by 99.8% to $1000.0 in 2024, then surged by 51500.0% to $516000.0 in 2025.
  • Its last three reported values are $516000.0 in Q4 2025, $32000.0 for Q3 2025, and $1000.0 during Q2 2025.